SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-21-000005
Filing Date
2021-03-03
Accepted
2021-03-03 06:41:16
Documents
17
Period of Report
2021-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20210303.htm   iXBRL 8-K 35854
2 EX-99.1 iseeyearendearningspressre.htm EX-99.1 77280
8 image_01.jpg GRAPHIC 38354
9 ivericlogo1.jpg GRAPHIC 11159
  Complete submission text file 0001410939-21-000005.txt   338220

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20210303.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isee-20210303_cal.xml EX-101.CAL 727
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isee-20210303_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20210303_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20210303_pre.xml EX-101.PRE 13207
10 EXTRACTED XBRL INSTANCE DOCUMENT isee-20210303_htm.xml XML 10989
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 21707134
SIC: 2834 Pharmaceutical Preparations